Loading…

The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature

Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecu...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2009-12, Vol.286 (1), p.121-128
Main Authors: Kashofer, K, Tschernatsch, M.M, Mischinger, H.J, Iberer, F, Zatloukal, K
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23
cites cdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23
container_end_page 128
container_issue 1
container_start_page 121
container_title Cancer letters
container_volume 286
creator Kashofer, K
Tschernatsch, M.M
Mischinger, H.J
Iberer, F
Zatloukal, K
description Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.
doi_str_mv 10.1016/j.canlet.2008.11.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66636523</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383508008720</els_id><sourcerecordid>66636523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhi0EotuFf4BQJCRuCXYcOw4HJFRRQCriQDlbs_aE9eKNF9tpKb8eh12pUi-c5jDvvPPxDCEvGG0YZfLNrjEwecxNS6lqGGsoY4_Iiqm-rftB0cdkRTntaq64OCPnKe0opaLrxVNyxgbGGFfDitxeb7GyLiEkrCJ6vIHJYBXGajvvYaq2eIAcDHo_e4jVb5zCjwhjrvbBok9vqy_Bo_mXM1uIYDJG9weyC1MFky2WNw5vF79cGnlX0pDniM_IkxF8wuenuCbfLz9cX3yqr75-_Hzx_qo2XcdzLXtr6ADDYHuBAkbeSehGQaHjFqUwylC1kXJjLJeqQz5s2Gj7wQpTsmps-Zq8PvoeYvg1Y8p679KyDkwY5qSllFyKlhfhqwfCXZjjVGbTTFAxtK0oE61Jd1SZGFKKOOpDdHuId5pRvWDRO33EohcsmjFdsJSylyfzebNHe1904lAE746CctPlYlEn47CQsC6iydoG978ODw2Md5Mz4H_iHab7XXRqNdXfltdYPoOqYtK3lP8F2iK21g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1505922544</pqid></control><display><type>article</type><title>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kashofer, K ; Tschernatsch, M.M ; Mischinger, H.J ; Iberer, F ; Zatloukal, K</creator><creatorcontrib>Kashofer, K ; Tschernatsch, M.M ; Mischinger, H.J ; Iberer, F ; Zatloukal, K</creatorcontrib><description>Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2008.11.011</identifier><identifier>PMID: 19111389</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Animals ; Cancer therapies ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - surgery ; Cell cycle ; Gene expression ; Gene expression profiles ; HCC ; Hematology, Oncology and Palliative Medicine ; Hepatocellular carcinoma ; Humans ; Kinases ; Liver cancer ; Liver Neoplasms - genetics ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; Medical prognosis ; Medical research ; Mice ; Mice, Nude ; Models, Biological ; Patients ; Studies ; Transplantation, Heterologous ; Tumors ; Vascular endothelial growth factor ; Xenografts</subject><ispartof>Cancer letters, 2009-12, Vol.286 (1), p.121-128</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2008 Elsevier Ireland Ltd</rights><rights>Copyright Elsevier Limited Dec 1, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</citedby><cites>FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19111389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kashofer, K</creatorcontrib><creatorcontrib>Tschernatsch, M.M</creatorcontrib><creatorcontrib>Mischinger, H.J</creatorcontrib><creatorcontrib>Iberer, F</creatorcontrib><creatorcontrib>Zatloukal, K</creatorcontrib><title>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.</description><subject>Animals</subject><subject>Cancer therapies</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Cell cycle</subject><subject>Gene expression</subject><subject>Gene expression profiles</subject><subject>HCC</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Models, Biological</subject><subject>Patients</subject><subject>Studies</subject><subject>Transplantation, Heterologous</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Xenografts</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkk1v1DAQhi0EotuFf4BQJCRuCXYcOw4HJFRRQCriQDlbs_aE9eKNF9tpKb8eh12pUi-c5jDvvPPxDCEvGG0YZfLNrjEwecxNS6lqGGsoY4_Iiqm-rftB0cdkRTntaq64OCPnKe0opaLrxVNyxgbGGFfDitxeb7GyLiEkrCJ6vIHJYBXGajvvYaq2eIAcDHo_e4jVb5zCjwhjrvbBok9vqy_Bo_mXM1uIYDJG9weyC1MFky2WNw5vF79cGnlX0pDniM_IkxF8wuenuCbfLz9cX3yqr75-_Hzx_qo2XcdzLXtr6ADDYHuBAkbeSehGQaHjFqUwylC1kXJjLJeqQz5s2Gj7wQpTsmps-Zq8PvoeYvg1Y8p679KyDkwY5qSllFyKlhfhqwfCXZjjVGbTTFAxtK0oE61Jd1SZGFKKOOpDdHuId5pRvWDRO33EohcsmjFdsJSylyfzebNHe1904lAE746CctPlYlEn47CQsC6iydoG978ODw2Md5Mz4H_iHab7XXRqNdXfltdYPoOqYtK3lP8F2iK21g</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Kashofer, K</creator><creator>Tschernatsch, M.M</creator><creator>Mischinger, H.J</creator><creator>Iberer, F</creator><creator>Zatloukal, K</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</title><author>Kashofer, K ; Tschernatsch, M.M ; Mischinger, H.J ; Iberer, F ; Zatloukal, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Cancer therapies</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Cell cycle</topic><topic>Gene expression</topic><topic>Gene expression profiles</topic><topic>HCC</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Models, Biological</topic><topic>Patients</topic><topic>Studies</topic><topic>Transplantation, Heterologous</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kashofer, K</creatorcontrib><creatorcontrib>Tschernatsch, M.M</creatorcontrib><creatorcontrib>Mischinger, H.J</creatorcontrib><creatorcontrib>Iberer, F</creatorcontrib><creatorcontrib>Zatloukal, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kashofer, K</au><au>Tschernatsch, M.M</au><au>Mischinger, H.J</au><au>Iberer, F</au><au>Zatloukal, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>286</volume><issue>1</issue><spage>121</spage><epage>128</epage><pages>121-128</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>19111389</pmid><doi>10.1016/j.canlet.2008.11.011</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2009-12, Vol.286 (1), p.121-128
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_66636523
source ScienceDirect Freedom Collection 2022-2024
subjects Animals
Cancer therapies
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - surgery
Cell cycle
Gene expression
Gene expression profiles
HCC
Hematology, Oncology and Palliative Medicine
Hepatocellular carcinoma
Humans
Kinases
Liver cancer
Liver Neoplasms - genetics
Liver Neoplasms - pathology
Liver Neoplasms - surgery
Medical prognosis
Medical research
Mice
Mice, Nude
Models, Biological
Patients
Studies
Transplantation, Heterologous
Tumors
Vascular endothelial growth factor
Xenografts
title The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A41%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20disease%20relevance%20of%20human%20hepatocellular%20xenograft%20models:%20Molecular%20characterization%20and%20review%20of%20the%20literature&rft.jtitle=Cancer%20letters&rft.au=Kashofer,%20K&rft.date=2009-12-01&rft.volume=286&rft.issue=1&rft.spage=121&rft.epage=128&rft.pages=121-128&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2008.11.011&rft_dat=%3Cproquest_cross%3E66636523%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1505922544&rft_id=info:pmid/19111389&rfr_iscdi=true